Table 1 Clinicopathologic features and EBV expression in gastric cancer
| Â | Â | EBV Expression | |||
|---|---|---|---|---|---|
| Â | Â | Negative | Positive | Total | p |
Gender | Female | 87 (37%) | 1 (0%) | 88 (37%) | 0.03 |
| Â | Male | 136 (58%) | 11 (5%) | 147 (63%) | Â |
Age | <65 | 111 (47%) | 7 (3%) | 118 (50%) | 0.77 |
| Â | > = 65 | 112 (48%) | 5 (2%) | 117 (50%) | Â |
Lymph node | Negative | 56 (25%) | 4 (2%) | 60 (27%) | 0.74 |
| Â | Positive | 157 (70%) | 8 (4%) | 165 (73%) | Â |
Type | Well/Moderately | 79 (34%) | 4 (2%) | 83 (35%) | 0.16 |
| Â | Poorly | 144 (62%) | 8 (4%) | 152 (65%) | Â |
Stage | I or II | 126 (54%) | 5 (2%) | 131 (56%) | 0.38 |
| Â | III or IV | 97 (41%) | 7 (3%) | 104 (44%) | Â |
Total | Â | 223 (95%) | 12 (5%) | 235 (100%) | Â |